BIONIK LABORATORIES CORP.: 10-Q filed 2016-11-14

Name: BIONIK LABORATORIES CORP.: 10-Q filed 2016-11-14
Creator: BIONIK LABORATORIES CORP.

What BIONIK LABORATORIES CORP. reported in its quarterly report filed 2016-11-14 (fiscal Q2 2017): 36 published measures, 100 facts as tagged in accession 0001144204-16-134420.

This filing

Form: 10-Q (quarterly report)
Filed: 2016-11-14
Fiscal period: fiscal Q2 2017
Accession: 0001144204-16-134420 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIONIK LABORATORIES CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-09-30	30,348,852	USD
At 2016-03-31	6,236,746	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2016-09-30	5,391,130	USD
At 2016-03-31	5,972,840	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2016-09-30	24,957,722	USD
At 2016-03-31	263,906	USD
At 2015-09-30	-373,684	USD
At 2015-03-31	-2,498,745	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2016-09-30	1,677,310	USD
At 2016-03-31	5,381,757	USD
At 2015-09-30	7,858,627	USD
At 2015-03-31	6,125,108	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-04-01 to 2016-09-30	-1,593,226	USD	183
2015-10-01 to 2016-03-31	208,645	USD	183
2015-04-01 to 2015-09-30	827,503	USD	183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-09-30	-13,245,206	USD
At 2016-03-31	-11,651,980	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	85,924,462	shares	92
2016-04-01 to 2016-09-30	87,232,426	shares	183
2015-07-01 to 2015-09-30	72,408,313	shares	92
2015-04-01 to 2015-09-30	61,491,674	shares	183

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	89,789,461	shares	92
2016-04-01 to 2016-09-30	87,232,426	shares	183
2015-07-01 to 2015-09-30	76,270,355	shares	92
2015-04-01 to 2015-09-30	70,064,316	shares	183

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	0.01	USD/shares	92
2016-04-01 to 2016-09-30	-0.02	USD/shares	183
2015-07-01 to 2015-09-30	0.03	USD/shares	92
2015-04-01 to 2015-09-30	0.01	USD/shares	183

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	0.01	USD/shares	92
2016-04-01 to 2016-09-30	-0.02	USD/shares	183
2015-07-01 to 2015-09-30	0.02	USD/shares	92
2015-04-01 to 2015-09-30	0.01	USD/shares	183

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2016-09-30	195,994	USD
At 2016-03-31	76,750	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	204,842	USD	92
2016-04-01 to 2016-09-30	424,090	USD	183
2015-07-01 to 2015-09-30	26,724	USD	92
2015-04-01 to 2015-09-30	1,324,282	USD	183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-09-30	2,263,879	USD
At 2016-03-31	6,159,996	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2016-09-30	5,048,256	USD
At 2016-03-31	5,972,840	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2016-09-30	419,862	USD
At 2016-03-31	320,871	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2016-04-21	27,888,979	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2016-09-30	93,892	USD
At 2016-03-31	0	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	1,807,323	USD	92
2016-04-01 to 2016-09-30	3,840,336	USD	183
2015-07-01 to 2015-09-30	1,182,845	USD	92
2015-04-01 to 2015-09-30	3,609,328	USD	183

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2016-09-30	294,027	USD
At 2016-03-31	0	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	6,264	USD	92
2016-04-01 to 2016-09-30	111,580	USD	183
2015-07-01 to 2015-09-30	0	USD	92
2015-04-01 to 2015-09-30	0	USD	183

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	813,773	USD	92
2016-04-01 to 2016-09-30	1,231,563	USD	183
2015-07-01 to 2015-09-30	768,301	USD	92
2015-04-01 to 2015-09-30	1,378,123	USD	183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2016-09-30	46,362,542	shares
At 2016-03-31	22,591,292	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2016-09-30	38,064,417	USD
At 2016-03-31	11,801,146	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2016-09-30	42,149	USD
At 2016-03-31	42,149	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2016-09-30	339,161	USD
At 2016-03-31	186,164	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2016-09-30	143,167	USD
At 2016-03-31	109,414	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2016-09-30	806,901	USD
At 2016-03-31	515,979	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2016-09-30	157,142	USD
At 2016-03-31	231,733	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	729,546	USD	92
2016-04-01 to 2016-09-30	-1,593,226	USD	183
2015-07-01 to 2015-09-30	2,318,758	USD	92
2015-04-01 to 2015-09-30	827,503	USD	183

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	577,853	USD	92
2016-04-01 to 2016-09-30	1,881,467	USD	183
2015-07-01 to 2015-09-30	372,342	USD	92
2015-04-01 to 2015-09-30	874,443	USD	183

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	23,950	USD	92
2016-04-01 to 2016-09-30	33,753	USD	183
2015-07-01 to 2015-09-30	15,478	USD	92
2015-04-01 to 2015-09-30	32,480	USD	183

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	2,530,605	USD	92
2016-04-01 to 2016-09-30	2,135,530	USD	183
2015-07-01 to 2015-09-30	3,501,603	USD	92
2015-04-01 to 2015-09-30	4,436,831	USD	183

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2016-04-01 to 2016-09-30	0	USD	183
2015-04-01 to 2015-09-30	4,552,409	USD	183

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-04-01 to 2016-09-30	87,402	USD	183
2015-04-01 to 2015-09-30	0	USD	183

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-04-01 to 2016-09-30	191,548	USD	183
2015-04-01 to 2015-09-30	78,071	USD	183

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2016-04-01 to 2016-09-30	-696,874	USD	183
2015-04-01 to 2015-09-30	-214,034	USD	183

Inspect the source

Entity: BIONIK LABORATORIES CORP. / CIK 0001508381
Captured: 2026-09-22 19:49 UTC
SEC response SHA-256: 5bb7fb15cbaa342375014f08f1afdc44fc44d4a568725cfe6cc78e258108a4c6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001508381.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))